Page last updated: 2024-10-22

amitriptyline and Cranial Nerve Diseases

amitriptyline has been researched along with Cranial Nerve Diseases in 2 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Cranial Nerve Diseases: Disorders of one or more of the twelve cranial nerves. With the exception of the optic and olfactory nerves, this includes disorders of the brain stem nuclei from which the cranial nerves originate or terminate.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Norris, BK1
Schweinfurth, JM1
Zadik, Y1
Benoliel, R1
Fleissig, Y1
Casap, N1

Other Studies

2 other studies available for amitriptyline and Cranial Nerve Diseases

ArticleYear
Management of recurrent laryngeal sensory neuropathic symptoms.
    The Annals of otology, rhinology, and laryngology, 2010, Volume: 119, Issue:3

    Topics: Adrenergic Uptake Inhibitors; Aged; Amines; Amitriptyline; Cough; Cranial Nerve Diseases; Cyclohexan

2010
Painful trigeminal neuropathy induced by oral bisphosphonate-related osteonecrosis of the jaw: a new etiology for the numb-chin syndrome.
    Quintessence international (Berlin, Germany : 1985), 2012, Volume: 43, Issue:2

    Topics: Aged; Alendronate; Amitriptyline; Analgesics, Non-Narcotic; Bisphosphonate-Associated Osteonecrosis

2012